Trump Proposes 100% Tariffs on Imported Generic Medications
President Trump announced plans to impose 100% tariffs on imported generic drugs starting August 2028, with a potential increase to 200% in the following year if manufacturers do not shift production back to the U.S. This move could lead to higher drug prices for consumers and significant cost pressures on generic pharmaceutical companies.
Topics: generic drugs manufacturing reshoring pharmaceuticals trade policy